180 related articles for article (PubMed ID: 25295683)
1. Association between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy.
Nathoo NA; Etminan M; Mikelberg FS
J Neuroophthalmol; 2015 Mar; 35(1):12-5. PubMed ID: 25295683
[TBL] [Abstract][Full Text] [Related]
2. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.
Campbell UB; Walker AM; Gaffney M; Petronis KR; Creanga D; Quinn S; Klein BE; Laties AM; Lewis M; Sharlip ID; Kolitsopoulos F; Klee BJ; Mo J; Reynolds RF
J Sex Med; 2015 Jan; 12(1):139-51. PubMed ID: 25358826
[TBL] [Abstract][Full Text] [Related]
3. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors.
Bella AJ; Brant WO; Lue TF; Brock GB
Can J Urol; 2006 Oct; 13(5):3233-8. PubMed ID: 17076943
[TBL] [Abstract][Full Text] [Related]
4. Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor Exposure.
Flahavan EM; Li H; Gupte-Singh K; Rizk RT; Ruff DD; Francis JL; Kinchen KS
Urology; 2017 Jul; 105():76-84. PubMed ID: 28336289
[TBL] [Abstract][Full Text] [Related]
5. Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction.
Thurtell MJ; Tomsak RL
Int J Impot Res; 2008; 20(6):537-43. PubMed ID: 18528398
[TBL] [Abstract][Full Text] [Related]
6. Erectile Dysfunction Agents and Nonarteritic Anterior Ischemic Optic Neuropathy.
Pomeranz HD
Neurol Clin; 2017 Feb; 35(1):17-27. PubMed ID: 27886893
[TBL] [Abstract][Full Text] [Related]
7. Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence?
Carter JE
J Neurol Sci; 2007 Nov; 262(1-2):89-97. PubMed ID: 17706972
[TBL] [Abstract][Full Text] [Related]
8. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Pinna A; Solinas G; Masia C; Zinellu A; Carru C; Carta A
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1328-32. PubMed ID: 18385045
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy.
Pomeranz HD
J Neuroophthalmol; 2016 Jun; 36(2):193-6. PubMed ID: 26720519
[TBL] [Abstract][Full Text] [Related]
10. Nonarteritic ischaemic optic neuropathy (NAION) after 36 h of intake of sildenafil citrate: first Egyptian case.
El-Domyati MM; El-Fakahany HM; Morad KE
Andrologia; 2009 Oct; 41(5):319-21. PubMed ID: 19737280
[TBL] [Abstract][Full Text] [Related]
11. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction.
McGwin G; Vaphiades MS; Hall TA; Owsley C
Br J Ophthalmol; 2006 Feb; 90(2):154-7. PubMed ID: 16424524
[TBL] [Abstract][Full Text] [Related]
12. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Following End-Stage Renal Disease.
Chang YS; Weng SF; Chang C; Wang JJ; Su SB; Huang CC; Wang JY; Jan RL
Medicine (Baltimore); 2016 Mar; 95(12):e3174. PubMed ID: 27015205
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?
Hatzimouratidis K
Curr Urol Rep; 2007 Nov; 8(6):482-90. PubMed ID: 18042329
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Stroke in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy: A Nationwide Retrospective Cohort Study.
Lee YC; Wang JH; Huang TL; Tsai RK
Am J Ophthalmol; 2016 Oct; 170():183-189. PubMed ID: 27521605
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of familial nonarteritic anterior ischemic optic neuropathy in a case series.
Wang MY; Sadun F; Levin LB; LaBree L; Feldon SE
J Neuroophthalmol; 1999 Jun; 19(2):144-7. PubMed ID: 10380139
[TBL] [Abstract][Full Text] [Related]
16. Nonarteritic anterior ischaemic optic neuropathy and its association with obstructive sleep apnoea: a health insurance database study.
Sun MH; Lee CY; Liao YJ; Sun CC
Acta Ophthalmol; 2019 Feb; 97(1):e64-e70. PubMed ID: 30171667
[TBL] [Abstract][Full Text] [Related]
17. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
Margo CE; French DD
Am J Ophthalmol; 2007 Mar; 143(3):538-9. PubMed ID: 17317413
[TBL] [Abstract][Full Text] [Related]
18. Risk of Ischemic Kidney Injury in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy: A Nationwide Population-based Study.
Lee JY; Park KA; Oh SY
Am J Ophthalmol; 2018 Mar; 187():153-157. PubMed ID: 29330063
[TBL] [Abstract][Full Text] [Related]
19. Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis.
Penedones A; Alves C; Batel Marques F
Acta Ophthalmol; 2020 Feb; 98(1):22-31. PubMed ID: 31559705
[TBL] [Abstract][Full Text] [Related]
20. Demographic, Systemic, and Ocular Factors Associated with Nonarteritic Anterior Ischemic Optic Neuropathy.
Cestari DM; Gaier ED; Bouzika P; Blachley TS; De Lott LB; Rizzo JF; Wiggs JL; Kang JH; Pasquale LR; Stein JD
Ophthalmology; 2016 Dec; 123(12):2446-2455. PubMed ID: 27659545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
